NEUROLOGY 2005;65:1239-1245
© 2005 American Academy of Neurology
Cognitive profile of patients with newly diagnosed Parkinson disease
Dino Muslimovi , MSc,
Bart Post, MD,
Johannes D. Speelman, MD, PhD and
Ben Schmand, PhD
From the Department of Neurology, Academic Medical Center, University of Amsterdam, the Netherlands; and CARPA Study Group (Drs. Post and Speelman).
address correspondence and reprint requests to Dr. D. Muslimovic, AMC Neurology, H2-222, P.O. Box 22660, 1100 DD Amsterdam, the Netherlands; e-mail: d.muslimovic{at}amc.uva.nl
Objective: To determine the frequency and pattern of cognitive dysfunction in patients with newly diagnosed Parkinson disease (PD) and to identify its demographic and clinical correlates.
Methods: A cohort of 115 consecutive patients with newly diagnosed PD and 70 healthy controls underwent a comprehensive neuropsychological assessment including tests of psychomotor speed, attention, language, memory, executive and visuospatial functions, as well as measures of affective status. Patients also received quantitative ratings of motor symptom severity and functional status. Neuropsychological performance of PD patients was compared with that of healthy controls and with available normative data. Independent demographic and clinical predictors of cognitive impairment were identified with multiple logistic regression analysis.
Results: Relative to controls, PD patients performed significantly worse on most cognitive measures. However, further analysis revealed that group differences in cognitive performance could mainly be explained by measures of immediate memory and executive function. Comparison with normative data showed that impairments were most frequent on measures of executive function, memory and psychomotor speed. In all, 24% of PD patients (4% of controls) displayed defective performance on at least three neuropsychological tests and were classified as cognitively impaired. Late onset of disease was an independent predictor of cognitive dysfunction in PD.
Conclusion: Cognitive impairments are common even in newly diagnosed Parkinson disease patients, with deficits being most prominent in the domains of memory and executive functions. Older age at disease onset is likely to be an important determinant of cognitive dysfunction in Parkinson disease.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the October 25 issue to find the link for this article.
Supported by the Prinses Beatrix Fonds (Grant PGO 01-0138 to B. Schmand).
Disclosure: The authors report no conflicts of interest.
Received April 27, 2005. Accepted in final form July 11, 2005.
Please
This article has been cited by other articles:
|
|
|
|
 
S. Hoops, S. Nazem, A. D. Siderowf, J. E. Duda, S. X. Xie, M. B. Stern, and D. Weintraub
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Neurology,
November 24, 2009;
73(21):
1738 - 1745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Nieuwboer, K. Baker, A.-M. Willems, D. Jones, J. Spildooren, I. Lim, G. Kwakkel, E. Van Wegen, and L. Rochester
The Short-Term Effects of Different Cueing Modalities on Turn Speed in People with Parkinson's Disease
Neurorehabil Neural Repair,
October 1, 2009;
23(8):
831 - 836.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. W. Olanow, M. B. Stern, and K. Sethi
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Neurology,
May 26, 2009;
72(21_Supplement_4):
S1 - S136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Aarsland, K. Bronnick, J. P. Larsen, O. B. Tysnes, G. Alves, and For the Norwegian ParkWest Study Group
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Neurology,
March 31, 2009;
72(13):
1121 - 1126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R H B Benedict, D Ramasamy, F Munschauer, B Weinstock-Guttman, and R Zivadinov
Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy
J. Neurol. Neurosurg. Psychiatry,
February 1, 2009;
80(2):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Benninger, D. Waldvogel, C. L. Bassetti, J.-F. Gagnon, M. Vendette, R. B. Postuma, and J. Montplaisir
REM SLEEP BEHAVIOR DISORDER PREDICTS COGNITIVE IMPAIRMENT IN PARKINSON DISEASE WITHOUT DEMENTIA
Neurology,
September 16, 2008;
71(12):
955 - 956.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Marighetto, S. Valerio, J. Philippin, V. Bertaina-Anglade, C. Drieu la Rochelle, R. Jaffard, and P. Morain
Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
J Psychopharmacol,
July 1, 2008;
22(5):
511 - 521.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Muslimovic, B. Post, J. D. Speelman, B. Schmand, R. J. de Haan, and For the CARPA Study Group
Determinants of disability and quality of life in mild to moderate Parkinson disease
Neurology,
June 3, 2008;
70(23):
2241 - 2247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, et al.
Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P
Neurology,
April 15, 2008;
70(16_Part_2):
1390 - 1396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Williams-Gray, A. Hampshire, R. A. Barker, and A. M. Owen
Attentional control in Parkinson's disease is dependent on COMT val158met genotype
Brain,
February 1, 2008;
131(2):
397 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Vendette, J. -F. Gagnon, A. Decary, J. Massicotte-Marquez, R. B. Postuma, J. Doyon, M. Panisset, and J. Montplaisir
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia
Neurology,
November 6, 2007;
69(19):
1843 - 1849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Verbaan, J Marinus, M Visser, S M van Rooden, A M Stiggelbout, H A M Middelkoop, and J J van Hilten
Cognitive impairment in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry,
November 1, 2007;
78(11):
1182 - 1187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Muslimovic, B. Post, J. D. Speelman, and B. Schmand
Motor procedural learning in Parkinson's disease
Brain,
November 1, 2007;
130(11):
2887 - 2897.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Bronnick, M. Emre, R. Lane, S. Tekin, and D. Aarsland
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2007;
78(10):
1064 - 1068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Williams-Gray, T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Brain,
July 1, 2007;
130(7):
1787 - 1798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Bronnick, U Ehrt, M Emre, P P De Deyn, K Wesnes, S Tekin, and D Aarsland
Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2006;
77(10):
1136 - 1142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
